Pulse Health (ASX:PHG) recently provided an update confirming guidance of FY15 underlying EBITDA growth from existing assets in excess of 20% above FY14.
The company is also currently in a process to exit non-core assets.
This includes the Gympie Hospital freehold, and when proceeds from the sale are received $6 million), the company will have a healthy cash balance in excess of $9 million.
At the end of last month the company said that it continues to progress a pipeline of acquisition and development opportunities.
Today the ASX granted the company a trading halt pending details of an acquisition.
The halt will remain in place until the opening of trade on Wednesday 8th July 2015, or earlier if an announcement is made to the market.
